Adjunct Professor, Department of Bioengineering
CEO and Co-Founder, 4D Molecular Therapeutics
davidhkirn@gmail.com
For more information, see: https://www.linkedin.com/in/davidkirnmd
Research Interests
Find more information at https://www.4dmt.com.
Education
Certificate of Business Excellence, Haas Business School
University of California, Berkeley
Fellowship, Medical Oncology
University of California, San Francisco
Clinical Research & Biostatistics Program Scholar
University of California, San Francisco
Internal Medicine Residency, Brigham and Women’s Hospital
Harvard Medical School
Doctor of Medicine (MD), Medicine
University of California, San Francisco
BA, Physiology, Physical Anthropology
University of California, Berkeley
Professional Experience
Adjunct Professor
UC Berkeley, Department of Bioengineering
Co-Founder & CEO, co-Chairman
4D Molecular Therapeutics
J & J Entrepreneur Innovator
Johnson & Johnson
SVP, Global Clinical R&D, Hematology/Oncology
Celgene
Founder, CEO & President of R&D
Jennerex Biotherapeutics
Professor, Visiting (Adjunct)
University of Oxford Medical School, Dept of Clinical Pharmacology
Founder & President
Kirn Oncology Biotherapeutics Consulting
Associate Professor (Senior Lecturer)
Imperial College London, Cancer Biotherapeutics & Oncolytic Virotherapy R&D Program
Assistant Professor (Adjunct)
UCSF, Dept Medicine, Div Medical Oncology
Vice President, R&D
Onyx Pharmaceuticals